Biodel to Present at Two Upcoming Investor Conferences

DANBURY, CT -- (Marketwired) -- 06/18/15 -- Biodel Inc. (NASDAQ: BIOD) management will be participating in two upcoming investor conferences.

• President and CEO Errol De Souza, PhD at the 2nd Annual ROTH Healthcare Day on Wednesday, June 24, 2015 in London, UK; and
• Chief Financial Officer Mr. Gary G. Gemignani and Chief Medical Officer Dr. Alan S. Krasner at the JMP Securities Life Sciences Conference on Wednesday, June 24, 2015 at 2:00 p.m. ET in New York, NY.

Interested parties can access a link to a live webcast of the JMP Securities Life Sciences Conference presentation from the News & Events section of the Biodel website, www.biodel.com. A live and archived webcast of the presentation will be accessible on the Biodel website at www.biodel.com under "Webcasts" in the "News & Events" section.

About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. Biodel's product candidates are developed by applying proprietary technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at www.biodel.com.

BIOD-G

   CONTACT:  Clayton Robertson +1 (646) 378 2964

Source: Biodel, Inc.

You May Also Be Interested In

• World Intellectual Property Day: OPPO Maintains Top 10 Global IP Ranking for Fifth Consecutive Year
• INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FiscalNote Holdings, Inc. and Encourages Investors to Contact the Firm
• Perk Labs Announces Closing of Non-Brokered Private Placements